RATS IMMUNIZED WITH CHOLINERGIC SYNAPTOSOMES - A MODEL FOR LAMBERT-EATON SYNDROME

被引:5
|
作者
CHAPMAN, J
RABINOWITZ, R
KORCZYN, AD
MICHAELSON, DM
机构
[1] TEL AVIV UNIV,SACKLER SCH MED,DEPT PHYSIOL & PHARMACOL,IL-69978 TEL AVIV,ISRAEL
[2] TEL AVIV UNIV,DR GEORGE S WISE CTR LIFE SCI,DEPT BIOCHEM,TEL AVIV,ISRAEL
关键词
acetylcholine release; autoantibodies; electromyography; Lambert‐Eaton myasthenic syndrome; Torpedo;
D O I
10.1002/mus.880130811
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lambert‐Eaton myasthenic syndrome (LEMS) is an autoimmune disorder characterized by reduced acetylcholine release at the neuromuscular junction. We report a model of the disease developed by active immunization of rats with purely cholinergic nerve terminals (synaptosomes) isolated from the Torpedo electric organ. Electromyographic studies of neuromuscular transmission in these rats showed a weak initial response followed by a pronounced incremental response to paired supramaximal stimuli (8 msec apart). There was no such response in control rats. There was no evidence of a postsynaptic transmission deficit in the synaptosomes immunized rats. We conclude that immunizing rats with Torpedo cholinergic nerve terminals causes a specific presynaptic dysfunction and may serve as a model for the study of LEMS. Copyright © 1990 John Wiley & Sons, Inc.
引用
收藏
页码:726 / 733
页数:8
相关论文
共 50 条
  • [41] Lambert-Eaton myasthenic syndrome: Electrodiagnostic finding and response to treatment
    Tim, RW
    Massey, JM
    Sanders, DB
    NEUROLOGY, 2000, 54 (11) : 2176 - 2178
  • [42] A Patient with Coexisting Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome
    Kim, Jee-Ae
    Lim, Young-Min
    Jang, Eun Hye
    Kim, Kwang-Kuk
    JOURNAL OF CLINICAL NEUROLOGY, 2012, 8 (03): : 235 - 237
  • [43] Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient
    Sha, Sharon J.
    Layzer, Robert B.
    MUSCLE & NERVE, 2007, 36 (01) : 115 - 117
  • [44] Post-exercise exhaustion in Lambert-Eaton myasthenic syndrome
    Oh, Shin J.
    Hatanaka, Yuki
    Ito, Eiichi
    Nagai, Taiichi
    CLINICAL NEUROPHYSIOLOGY, 2014, 125 (02) : 411 - 414
  • [45] THERAPEUTIC APPROACHES TO LAMBERT-EATON MYASTHENIC SYNDROME IN THE INTRAINDIVIDUAL COMPARISON
    JOST, WH
    MIELKE, U
    SCHIMRIGK, K
    WIENER KLINISCHE WOCHENSCHRIFT, 1991, 103 (20) : 629 - 632
  • [46] Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma
    Shipley, E.
    Krim, E.
    Deminiere, C.
    Lagueny, A.
    REVUE NEUROLOGIQUE, 2008, 164 (01) : 72 - 76
  • [47] The association of systemic lupus erythematosus and Lambert-Eaton myasthenic syndrome
    Deodhar, A
    Norden, J
    So, Y
    Bennett, R
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (07) : 1292 - 1294
  • [48] Neurogenic electromyographic activity in a patient with non-paraneoplasic Lambert-Eaton syndrome
    Lapergue, B.
    Lefaucheur, J. -P.
    Bourahoui, A.
    Nordine, T.
    Hosseini, H.
    Creange, A.
    REVUE NEUROLOGIQUE, 2007, 163 (12) : 1227 - 1231
  • [49] Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
    Pascuzzi, Robert
    Bodkin, Cynthia
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 3001 - 3022
  • [50] An autoimmune channelopathy associated with cancer: Lambert-Eaton myasthenic syndrome
    Takamori, M
    INTERNAL MEDICINE, 1999, 38 (02) : 86 - 96